Your browser doesn't support javascript.
loading
Author Correction: The state of the art in secondary pharmacology and its impact on the safety of new medicines.
Brennan, Richard J; Jenkinson, Stephen; Brown, Andrew; Delaunois, Annie; Dumotier, Bérengère; Pannirselvam, Malar; Rao, Mohan; Ribeiro, Lyn Rosenbrier; Schmidt, Friedemann; Sibony, Alicia; Timsit, Yoav; Sales, Vicencia Toledo; Armstrong, Duncan; Lagrutta, Armando; Mittlestadt, Scott W; Naven, Russell; Peri, Ravikumar; Roberts, Sonia; Vergis, James M; Valentin, Jean-Pierre.
Afiliação
  • Brennan RJ; Sanofi, Cambridge, MA, USA. richbrennan@gmail.com.
  • Jenkinson S; Pfizer, La Jolla, CA, USA.
  • Brown A; Metrion Biosciences, San Diego, CA, USA.
  • Delaunois A; GSK, Stevenage, UK.
  • Dumotier B; UCB Biopharma, Braine-l'Alleud, Belgium.
  • Pannirselvam M; Novartis Biomedical Research, Basel, Switzerland.
  • Rao M; Vertex Pharmaceuticals, Boston, MA, USA.
  • Ribeiro LR; GSK, Waltham, MA, USA.
  • Schmidt F; Janssen Research & Development, San Diego, CA, USA.
  • Sibony A; Neurocrine Biosciences, San Diego, CA, USA.
  • Timsit Y; UCB Biopharma, Braine-l'Alleud, Belgium.
  • Sales VT; AstraZeneca, Cambridge, UK.
  • Armstrong D; Grunenthal, Berkshire, UK.
  • Lagrutta A; Sanofi, Frankfurt, Germany.
  • Mittlestadt SW; UCB Biopharma, Braine-l'Alleud, Belgium.
  • Naven R; Novartis Biomedical Research, Cambridge, MA, USA.
  • Peri R; Blueprint Medicines, Cambridge, MA, USA.
  • Roberts S; Takeda Pharmaceuticals, Cambridge, MA, USA.
  • Vergis JM; Novartis Biomedical Research, Cambridge, MA, USA.
  • Valentin JP; Armstrong Pharmacology, Macclesfield, UK.
Nat Rev Drug Discov ; 23(7): 563, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38886593
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article